<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="144824">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01215318</url>
  </required_header>
  <id_info>
    <org_study_id>KEK-ZH-NR: 2010-0014</org_study_id>
    <nct_id>NCT01215318</nct_id>
  </id_info>
  <brief_title>Etiology and Prevention of Urinary Contamination of Vaginal Tampons During (18F)-FDG PET/CT Examinations</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Zurich</source>
  <brief_summary>
    <textblock>
      The etiology of FDG uptake in vaginal tampons during PET/CT examinations remains unclear and
      can potentially impaire image interpretation.

      The aim of this study is to determine the etiology of this artefact and devine potential
      ways how to prevent it.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2010</start_date>
  <completion_date>July 2010</completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
  </study_design_info>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Prevention of FDG Uptake in Vaginal Tampons</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Feasability</intervention_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Prevention of FDG uptake in vaginal tampons
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria: premenopausal women with known or suspected malignancies who regularly
        used VTs during menstruation and thus were familiar with their use

        Exclusion criteria: No cervical or genital carcinoma. No vaginal infection.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>48 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>01 Studienregister MasterAdmins</last_name>
    <role>Study Director</role>
    <affiliation>UniversitaetsSpital Zuerich</affiliation>
  </overall_official>
  <location>
    <facility>
      <address>
        <city>Zurich</city>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>October 2010</verification_date>
  <lastchanged_date>October 4, 2010</lastchanged_date>
  <firstreceived_date>October 4, 2010</firstreceived_date>
  <responsible_party>
    <name_title>von Schulthess Gustav, Prof. Dr. med.</name_title>
    <organization>University Hospital Zurich, NUK Klinik f. Nuklearmedizin</organization>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
